Can I use HS-6 300693 for active pharmaceutical ingredients?

No, HS-6 300693 is specifically for placebos and clinical trial kits. Active ingredients would likely fall under a different classification.

Do I need special permits for importing HS-6 300693 items?

Yes, importing clinical trial kits may require specific permits or documentation, depending on your country’s regulations.

What is the difference between HS-6 300693 and HS-6 300694?

HS-6 300693 is for measured doses in clinical trials, while HS-6 300694 pertains to unmeasured doses or other pharmaceutical goods.

How should I package products under HS-6 300693?

Products should be packaged in a way that clearly indicates they are for clinical trials, with precise dosage information included.

Are there quantity limits for shipments classified under HS-6 300693?

There may be quantity limits depending on the regulations of the importing country, so it's best to check with customs authorities.

Can I include both placebos and active drugs in the same shipment under HS-6 300693?

You should classify active drugs separately, as HS-6 300693 is specifically for placebos and clinical trial kits.

What documentation is needed for HS-6 300693?

Documentation typically includes import permits, invoices detailing the contents, and any relevant clinical trial approvals.

HS-6 300693: Pharmaceutical goods; placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses

Plain-language overview

Use HS-6 300693 when importing or exporting clinical trial kits that include placebos and are packaged in measured doses. For example, a shipment containing 500 placebo tablets for a clinical trial should be classified under this code.

This HS-6 line specifically covers pharmaceutical goods designed for clinical trials, particularly those that are blinded or double-blinded. Unlike HS-6 300694, which pertains to unmeasured doses, this code emphasizes the importance of precise dosage in trial settings.

When considering HS-6 300693, it’s essential to ensure that the products are intended for recognized clinical trials. This distinguishes them from general pharmaceutical products that might not meet the same regulatory standards.

If you are dealing with clinical trial kits that include both active ingredients and placebos, you might need to classify those components separately, possibly under HS-6 300690 for other pharmaceutical goods.

Keywords & topics

Useful terms traders and brokers use for this HS-6 subheading.

clinical trial kits · placebo tablets · measured doses · blinded trials · pharmaceutical goods · investigational drugs · clinical research supplies · pharmaceutical products · double-blinded studies · packaged placebos · trial kit classification · research study materials

Examples

Drawn from the official tariff wording for this HS-6 subheading. Always confirm against your published schedule and legal notes.

500 placebo tablets for a double-blinded clinical trial
Clinical trial kit containing measured doses of investigational drugs
Packaged placebo injections for a medical study
Blinded clinical trial kits with both active and placebo components
Trial kits with pre-measured doses for patient administration
Placebo capsules in blister packs for a clinical research study
Measured dose vials of placebos for use in clinical trials
Clinical trial supplies including placebos for randomized studies